From our Thought Leaders in Health Law video series:  The U.S. Department of Justice (DOJ) collected $5.6 billion in False Claims Act recoveries in fiscal year (FY) 2021.

That is over twice as much as 2020, and a record 90 percent of the total was collected from the health care and life sciences industries.

DOJ’s health care recoveries in government-initiated actions were also more than double the total recoveries in actions initiated by whistleblowers.

Health care enforcement targeted:

  • billing for unnecessary medical services,
  • solicitation or payment of kickbacks for goods or services paid for by federal health care programs, and
  • risk adjustment fraud related to Medicare Advantage programs.

The record-breaking year in FY 2021 shows that the pandemic has not weakened enforcement activity, especially for the health care and life sciences industries. Comprehensive and effective compliance is more important now than ever.

To dive deeper into these stats and their impact on health care companies, read more from attorneys George Breen, Erica Sibley Bahnsen, Daniel Fundakowski, and Elizabeth Harris:

Health Law Advisor:  “DOJ Releases FY 2021 False Claims Act Recoveries: A Record-Shattering Year for Health Care and Life Sciences Enforcement, with Over $5 Billion Collected”

Law360:  “FCA Trends to Watch for Health, Life Sciences Companies”

The Thought Leaders in Health Law® video series tracks the latest trends in multiple areas of the health care and life sciences industries, featuring attorneys and advisors from Epstein Becker Green and EBG Advisors.